Categories: HealthcareNews

Vent Creativity Appoints Paul Abrams as Vice President of Sales to Lead Commercial Growth

NEW YORK–(BUSINESS WIRE)–Vent Creativity, a medical technology company advancing AI-enabled surgical planning, today announced the appointment of Paul Abrams as Vice President of Sales. Abrams will oversee the company’s commercial strategy and execution as Vent Creativity expands adoption of its digital twin platform for orthopedic surgery.




Vent Creativity’s software enables surgeons to create a patient-specific digital twin of the knee, providing enhanced preoperative insight into ligament tensioning and bone density. The platform integrates with existing surgical systems, supporting more informed clinical decision-making and improved procedural confidence before entering the operating room.

Abrams brings more than 30 years of experience in sales leadership, commercialization, and operational growth across healthcare, medical devices, and software-driven technologies. His background includes building scalable sales organizations, translating complex clinical solutions into clear value propositions, and supporting emerging technologies through early market adoption and growth.

“Paul brings the commercial discipline and healthcare experience we need at this stage of our growth,” said Gokce (Gilly) Yildirim, Chief Executive Officer of Vent Creativity. “He understands how to align clinical value with hospital economics and surgeon workflows, which is critical as we expand adoption across health systems and surgical centers.”

As Vice President of Sales, Abrams will work closely with Vent Creativity’s executive, clinical, and engineering teams to establish a disciplined go-to-market strategy, refine messaging for surgeons and healthcare systems, and build the commercial infrastructure required to support long-term growth.

“Vent Creativity is addressing a real clinical need by giving surgeons better visibility and confidence before surgery,” said Abrams. “The opportunity now is execution—aligning clinical value with a clear commercial strategy that supports adoption at scale.”

With Abrams joining the leadership team, Vent Creativity aims to accelerate market adoption and strengthen its position as a trusted surgical planning partner for orthopedic surgeons and healthcare organizations.

Contacts

Gokce (Gilly) Yildirim, CEO Vent Creativity

973 946 6994

info@ventcreativity.com

Staff

Recent Posts

AEON Clinic Announces Next Generation Medicine Congress 2026 Event: A Global Convergence on Human Longevity in Dubai

AEON Clinic Elevates Dubai to Global Hub for Longevity Science, A Definitive Four-Day Summit Defining…

47 minutes ago

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

1 day ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

1 day ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

1 day ago

Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles

Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…

1 day ago

Enzon Announces Commencement of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock in Connection With Viskase Merger

CRANFORD, N.J., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTCQB: ENZN) (“Enzon” or…

1 day ago